跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Gaviscon Double Action - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Gaviscon Double Action
Approved
STANDARD
Gaviscon Double Action
Reckitt Benckiser Healthcare (UK) Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
908f93e39204d7aa
Company
Reckitt Benckiser Healthcare (UK) Limited
Type
Standard
Approval Details
Approval Id
908f93e39204d7aa
Drug Approval Philippines Name
Gaviscon Double Action
Product Name
Gaviscon Double Action
Registration Number
DR-XY43337
Brand Name
Gaviscon Double Action
Generic Name
Sodium Alginate + Sodium Bicarbonate + Calcium Carbonate
Dosage Form
Suspension
Dosage Strength
500mg / 213 mg / 325mg per 10mL
Manufacturer
Reckitt Benckiser Healthcare (UK) Limited
Importer
Reckitt Benckiser Healthcare (Philippines) Inc.
Company Detail Path
/organization/reckitt-benckiser-healthcare-uk-limited
Issuance Date
27 October 2023
Expiry Date
03 April 2029
Pharmacologic Category
Antacid
Classification
Over-the-Counter (OTC)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
908f93e39204d7aa
Type
Standard
Back to Philippines FDA Approvals